Y0001573
Atovaquone for system suitability
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 95233-18-4
Synonym(S): Atovaquone, Mepron, trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 15 MG | Y0001573-15-MG | In Stock | ₹ 14,072.50 |
Y0001573 - 15 MG
In Stock
Quantity
1
Base Price: ₹ 14,072.50
GST (18%): ₹ 2,533.05
Total Price: ₹ 16,605.55
grade
pharmaceutical primary standard
API family
atovaquone
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
OC1=C([C@H]2CC[C@@H](CC2)c3ccc(Cl)cc3)C(=O)c4ccccc4C1=O
InChI
1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,26H,5-8H2/t13-,15-
InChI key
KUCQYCKVKVOKAY-CTYIDZIISA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Atovaquone Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 12,638.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Atovaquone United States Pharmacopeia (USP) Reference Standard | 95233-18-4 | 200MG | -- | ₹ 47,632.80 | ||
eMolecules Ambeed / 2-(trans-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-14-dione / 1mg / 665578297 / A242112 / / 95233-18-4 / MFCD00889188 / 366.840 / C22H19ClO3 | -- | ₹ 2,057.68 | ||
Sigma Aldrich Fine Chemicals Biosciences Atovaquone >=98% (HPLC) | 95233-18-4 | 50MG | -- | ₹ 35,106.05 | ||
Sigma Aldrich Fine Chemicals Biosciences Atovaquone | 95233-18-4 | | 10mg | -- | ₹ 8,907.12 | ||
eMolecules 2-(trans-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione | 95233-18-4 | MFCD00889188 | 1g | -- | ₹ 4,563.92 | ||
Sigma Aldrich Fine Chemicals Biosciences Atovaquone European Pharmacopoeia (EP) Reference Standard | 95233-18-4 | | -- | ₹ 16,681.27 | ||
Atovaquone | -- | ₹ 10,911.60 | ||
Atovaquone | -- | ₹ 14,072.50 | ||
Atovaquone | -- | ₹ 979.00 - ₹ 41,118.00 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Atovaquone for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Atovaquone is an anti-protozoal mitochondrial electron transport inhibitor; Antimalarial; Antipneumocystic, and has also been used to treat toxoplasmosis. It is an analog of protozoan mitochondrial protein ubiquinone, and acts by inhibiting the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable